NEU 2.38% $12.70 neuren pharmaceuticals limited

BP report, page-13

  1. 232 Posts.
    lightbulb Created with Sketch. 43
    2HCY16? "Trofinetide provides an opportunity potentially to be the first approved therapy for one or more of these important indications." You're having a laugh BP!

    Day 1:
    Trading Halt Regarding Results
    Day 3:
    Positive Results from Intrepid
    Day 4:
    Trading Halt Regarding Offer from Novartis
    Day 5:
    Trading Halt Regarding Counter Offer from Vertex
    AIMO

    Can't be long now, looking forward to the kickoff!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.